Navigation Links
AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
Date:1/6/2009

CARLSBAD, Calif., Jan. 6 /PRNewswire/ -- AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that the company has been invited and has accepted to present at the JPMorgan Healthcare Conference, which will be held January 12-15, 2009 at the Westin St. Francis Hotel in San Francisco, CA. At this conference, Fareed Kureshy, President & CEO will provide an overview of the Company at 11:00am on Tuesday, January 13, 2009.

About JPMorgan 27th Annual Healthcare Conference: JPMorgan's premier annual conference on the healthcare industry will feature more than 300 public and private companies over four days of simultaneous sessions.

About AutoGenomics

AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed an automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine. www.autogenomics.com


'/>"/>
SOURCE AutoGenomics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. AutoGenomics to Present at Cowen Health Care Conference on March 17, 2008
2. AutoGenomics Invited to Present at the JPMorgan Healthcare Conference
3. WuXi AppTec VP and GM Invited to Join the AAMI Standards Board
4. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
5. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
6. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
7. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
8. Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
9. Thoratec Presentation at J.P. Morgan Conference to be Webcast
10. West to Present at Upcoming Conferences
11. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)...  Ascendis Pharma A/S, a biotechnology company that ... unmet medical needs, today announced positive six-month interim ... to evaluate once-weekly TransCon Growth Hormone in children ... analysis consists of 25 patients, representing approximately 50% ... completing all six months of treatment. ...
(Date:12/13/2014)... Dec. 12, 2014 /CNW/ - MaRS and Virgin Unite Canada, ... they have joined forces to support Canadian entrepreneurs tackling social ... Group Founder was at the MaRS Centre to announce the ... impact venture fund. This fund has $1 million in seed ... Vancouver -based Mindset Social Innovation Foundation, founded by ...
(Date:12/13/2014)... The DNA Microarray market market was ... expected to grow at a CAGR of 15.2% ... TOC of the DNA Microarray for an in-depth ... help of various tables and figures. , ... consists of instrument, consumables, and services, where the ...
(Date:12/13/2014)... 2014 The “Global Synthetic Biology ... drivers, threats, opportunities, and challenges. , The global ... players, namely, Thermo Fisher Scientific, Inc. (U.S.), DuPont ... jointly accounted for approximately ~65% of the total ... Copy for This Report @ http://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3
... Microscope Series Positioned at the Center of the Most Advanced ... ... Instruments, Inc., (http://www.nikoninstruments.com ) today announced the launch of its ... the,new Ti offers improved system speed, increased flexibility and efficient,multi-mode ...
... - Canadian Biotechnology Company demonstrates the technical feasibility of ... in safflower - ... TSX symbol: SBS, ... company developing a portfolio of therapeutic,proteins for metabolic and cardiovascular diseases, ...
... Nominated Actress Shares Her Personal Story and Tips for Better Blood ... ... of the more,than 20 million Americans living with diabetes, Emmy nominated actress ... diabetes care, to urge other Americans with diabetes to reach,better levels of ...
Cached Biology Technology:Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting 2Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting 3SemBioSys announces 2007 third quarter results 2SemBioSys announces 2007 third quarter results 3SemBioSys announces 2007 third quarter results 4SemBioSys announces 2007 third quarter results 5SemBioSys announces 2007 third quarter results 6SemBioSys announces 2007 third quarter results 7SemBioSys announces 2007 third quarter results 8SemBioSys announces 2007 third quarter results 9SemBioSys announces 2007 third quarter results 10SemBioSys announces 2007 third quarter results 11SemBioSys announces 2007 third quarter results 12Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 2Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 3Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 4
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in ... sensors in biomedical applications. Chemical sensors help in ... diagnosis during surgical procedures. The Global Chemical Sensor ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
(Date:12/10/2014)... -- Valencell, a leader in performance biometric data sensor technology, ... its licensees for highly accurate, clinically validated biometric technology. ... from fitness and health sectors, but first responders/military and ... only as useful as the biometric data it delivers. ... long-term mass consumer adoption of wearable products," said Dr. ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Not knowing which way is up can have deadly ... spatial disorientation, is responsible for up to 10 percent ... 90 percent of these being fatal, according to the ... no spatial disorientation accidents in space, it is a ...
... feel the tell-tale tug of tiny concentrations of pathogens ... sterilizedor even heldas they are ephemeral and weightless. The ... a patented "optical tweezers" technique for detecting and measuring ... virus on a surface. NIST has issued a non-exclusive ...
... from satellites now allow scientists to monitor changes to water ... sheets and even under the ground. As the climate changes, ... predicting future impacts in different regions. Sea level rise ... it is much more difficult to model and predict than ...
Cached Biology News:Space researchers developing tool to help disoriented pilots 2Space researchers developing tool to help disoriented pilots 3Measuring water from space 2Measuring water from space 3
Mycoplasma and virus tested...
Edited by I.H. Pawlowitzki, J.H. Edwards and E.A. Thompson (1997) • This volume covers: Linkage in dominant recessive and oligogenic disease, Model free (non-parametric) methods, Tools for gene ...
...
... & visualization software. See ... samples. Combine Sequest and ... confidence. Get more detailed ... your MS/MS experiments.14 day ...
Biology Products: